NEW YORK, August 16, 2017 /PRNewswire/ --
If you want a Stock Review on VAR, MYO, SENS, or XTNT then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Tuesday, benchmark US indices were mixed as the NASDAQ Composite closed the trading session down 0.11%; the Dow Jones Industrial Average edged 0.02% higher; and the S&P 500 was down 0.05%. US markets saw a mixed session as 2 sectors closed in green, 5 sectors finished in red, and 2 sector ended flat for the day. Pre-market today, DailyStockTracker.com reviews these four Medical Appliances & Equipment stocks: Varian Medical Systems Inc. (NYSE: VAR), Myomo Inc. (NYSE MKT: MYO), Senseonics Holdings Inc. (NYSE MKT: SENS), and Xtant Medical Holdings Inc. (NYSE MKT: XTNT). Access DailyStockTracker.com's free research reports for this morning's stocks line-up at:
Varian Medical Systems
Palo Alto, California headquartered Varian Medical Systems Inc.'s stock finished Tuesday's session 0.83% higher at $99.22. A total volume of 587,993 shares was traded. The Company's shares have advanced 18.15% in the last twelve months and 24.80% on an YTD basis. The stock is trading above its 200-day moving average by 10.96%. Furthermore, shares of Varian Medical Systems, which designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide, have a Relative Strength Index (RSI) of 47.21. Free research report on VAR is available at:
Shares in Cambridge, Massachusetts headquartered Myomo Inc. ended at $6.75, down 7.02% from the last trading session. The stock recorded a trading volume of 126,251 shares. The stock is trading below its 50-day moving average by 35.60%. Moreover, shares of Myomo, which provides expanded mobility solutions for patients suffering from neurological disorders and upper limb paralysis in the US, have an RSI of 32.94. The complimentary research report on MYO can be downloaded at:
Germantown, Maryland headquartered Senseonics Holdings Inc.'s stock ended yesterday's session 4.27% lower at $2.24 with a total trading volume of 326,944 shares. The Company's shares have advanced 61.15% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 12.26% and 2.24%, respectively. Additionally, shares of Senseonics Holdings, which designs, develops, and commercializes glucose monitoring systems for people with diabetes primarily in Europe, have an RSI of 50.46. Visit us today and access our complete research report on SENS at:
On Tuesday, shares in Belgrade, Montana headquartered Xtant Medical Holdings Inc. recorded a trading volume of 694,388 shares. The stock finished the day 7.10% lower at $0.66. The Company's shares have advanced 24.57% in the previous three months and 19.93% since the start of this year. The stock is trading above its 200-day moving average by 13.79%. Furthermore, shares of Xtant Medical Holdings, which develops, manufactures, and markets regenerative medicine products and devices in the US and internationally, have an RSI of 43.16. Get free access to your research report on XTNT at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA